Tse-Ching Chen Selected Research

Hepatocellular Carcinoma (Hepatoma)

8/2017	Composite hepatocellular carcinoma and small cell carcinoma with early nodal metastasis: A case report.
7/2016	Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
4/2016	Severe Hepatitis Promotes Hepatocellular Carcinoma Recurrence via NF-κB Pathway-Mediated Epithelial-Mesenchymal Transition after Resection.
2/2016	HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100.
9/2015	Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
9/2015	Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas.
2/2014	Segregation of signaling proteins as prognostic predictors for local recurrence and distant metastasis in hepatocellular carcinoma.
10/2013	Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
6/2013	The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.
7/2012	Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tse-Ching Chen Research Topics

Disease

50	Neoplasms (Cancer) 01/2023 - 03/2002
18	Hepatocellular Carcinoma (Hepatoma) 08/2017 - 03/2002
9	Infections 01/2023 - 09/2009
9	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2011
7	Human Influenza (Influenza) 01/2023 - 04/2013
7	Cholangiocarcinoma 03/2022 - 04/2005
7	Neoplasm Metastasis (Metastasis) 07/2016 - 08/2006
6	Inflammation (Inflammations) 01/2023 - 05/2011
6	Adenocarcinoma 05/2022 - 02/2002
6	Carcinogenesis 01/2022 - 02/2006
4	Hepatitis 01/2020 - 04/2007
4	Liver Diseases (Liver Disease) 11/2018 - 04/2010
3	Epstein-Barr Virus Infections 04/2022 - 10/2006
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2016
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2018 - 01/2012
3	Carcinoma (Carcinomatosis) 01/2017 - 04/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2012 - 05/2008
2	Pneumonia (Pneumonitis) 01/2023 - 04/2013
2	Fistula 01/2023 - 07/2011
2	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 12/2005
2	Disease Progression 05/2022 - 09/2015
2	Microsatellite Instability 01/2020 - 12/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 05/2009
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 11/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018 - 05/2015
2	Hepatitis B 07/2012 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 03/2012 - 01/2012
2	Non-alcoholic Fatty Liver Disease 05/2011 - 04/2010
2	Nasopharyngeal Carcinoma 04/2011 - 10/2006
2	Fibrosis (Cirrhosis) 09/2008 - 04/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Hemangiosarcoma (Angiosarcoma) 01/2023
1	Lung Neoplasms (Lung Cancer) 05/2022
1	Acute Cholecystitis 09/2021
1	Leukoplakia 05/2021
1	Laryngopharyngeal Reflux 05/2021
1	Laryngeal Neoplasms (Laryngeal Cancer) 05/2021
1	Polyps 05/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2006
7	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2011
7	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2011
6	MucinsIBA 01/2023 - 05/2002
6	RNA (Ribonucleic Acid)IBA 12/2019 - 09/2006
5	AntigensIBA 01/2023 - 03/2015
5	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 01/2007
4	Neuraminidase (Sialidase)IBA 01/2023 - 03/2015
4	Hemagglutinins (Hemagglutinin)IBA 01/2023 - 01/2017
4	Chromogranin AIBA 08/2017 - 04/2011
3	Cadherins (E-Cadherin)IBA 05/2021 - 04/2016
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 01/2014
3	CytokinesIBA 03/2018 - 04/2013
3	Interleukin-6 (Interleukin 6)IBA 03/2018 - 02/2014
3	Messenger RNA (mRNA)IBA 02/2012 - 02/2009
3	Protein Isoforms (Isoforms)IBA 01/2012 - 09/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2022 - 11/2014
2	LigandsIBA 01/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 05/2015
2	Antiviral Agents (Antivirals)IBA 11/2019 - 09/2008
2	Oseltamivir (Tamiflu)FDA Link 11/2019 - 01/2017
2	GlypicansIBA 08/2017 - 07/2012
2	SynaptophysinIBA 08/2017 - 04/2011
2	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2012
2	Long Noncoding RNAIBA 07/2016 - 09/2015
2	Trastuzumab (Herceptin)FDA Link 01/2016 - 07/2015
2	S100 Proteins (S 100 Protein)IBA 01/2016 - 08/2006
2	CateninsIBA 12/2014 - 07/2012
2	Imatinib Mesylate (Gleevec)FDA Link 11/2014 - 02/2012
2	AlbuminsIBA 05/2013 - 01/2013
2	lipoarabinomannan (LAM)IBA 01/2012 - 09/2011
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2012 - 09/2009
2	Actins (F Actin)IBA 06/2011 - 09/2006
2	Fatty AlcoholsIBA 05/2011 - 04/2010
2	Keratins (Keratin)IBA 04/2011 - 01/2011
2	ParaffinIBA 02/2011 - 01/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2009 - 09/2008
2	Prednisolone (Predate)FDA LinkGeneric 11/2002 - 02/2002
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Interleukin-17 ReceptorsIBA 01/2023
1	TNF Receptor-Associated Factor 4IBA 01/2023
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2023
1	aristolochic acid I (aristolochic acid)IBA 01/2023
1	Chemokine ReceptorsIBA 01/2023
1	CrizotinibIBA 05/2022
1	Epstein-barr virus BALF5 proteinIBA 04/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	alloinIBA 11/2019

Therapy/Procedure

7	Hepatectomy 03/2022 - 03/2005
7	Therapeutics 01/2022 - 09/2008
5	Gastrectomy 01/2020 - 08/2014
5	Drug Therapy (Chemotherapy) 01/2018 - 02/2002
2	Immunotherapy 01/2023 - 01/2018
2	Colectomy 01/2022 - 08/2020
2	Precision Medicine 04/2021 - 03/2018
2	Adjuvant Chemotherapy 01/2020 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 12/2019 - 08/2014
2	Liver Transplantation 10/2013 - 01/2012
1	Cholecystostomy 09/2021